https://www.optimumcomms.com/wp-content/uploads/2023/12/Poolbeg_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-01-02 09:01:172025-01-02 11:51:43Combination of Poolbeg and HOOKIPA Pharma Inc.
https://www.optimumcomms.com/wp-content/uploads/2023/12/Poolbeg_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-01-02 09:01:172025-01-02 11:51:43Combination of Poolbeg and HOOKIPA Pharma Inc.
https://www.optimumcomms.com/wp-content/uploads/2023/06/Novo_Holdings23_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-23 11:53:432024-12-23 11:53:43European Energy and Novo Holdings announce joint venture to triple renewable energy capacity of German onshore wind parks
https://www.optimumcomms.com/wp-content/uploads/2023/06/Sequana_Medical_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-23 08:38:092024-12-23 08:38:09Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis
https://www.optimumcomms.com/wp-content/uploads/2024/12/Targed-logo.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-19 08:51:062024-12-19 08:58:07TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001, a groundbreaking thrombolytic in acute ischemic stroke (AIS) and TTP
https://www.optimumcomms.com/wp-content/uploads/2024/10/Ottimo_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-19 08:24:592024-12-19 08:24:59Ottimo Pharma Raises over $140 Million in Series A Financing
https://www.optimumcomms.com/wp-content/uploads/2023/06/Novo_Holdings23_Logo_300x180px-80x80-4.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-19 06:30:272024-12-19 08:35:51Novo Holdings and SUBRA join forces to accelerate development of innovative superconductor technology for power transmission and fusion energy
https://www.optimumcomms.com/wp-content/uploads/2023/06/NovoFund_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-18 08:39:002024-12-18 08:39:00Novo Nordisk Foundation grants €134.1 million to establish the Biotechnology Research Institute for the Green Transition (BRIGHT) in Denmark
https://www.optimumcomms.com/wp-content/uploads/2023/06/NovoFund_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-17 10:06:052024-12-17 14:20:41Denmark’s new AI supercomputer Gefion ranked as 7th fastest storage systems in the world
https://www.optimumcomms.com/wp-content/uploads/2023/02/Neophare_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-16 08:32:112024-12-16 08:32:11NeoPhore appoints Michael Shih as Chief Executive Officer
https://www.optimumcomms.com/wp-content/uploads/2023/06/Synaffix_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-12 12:43:352024-12-12 12:43:35Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion
https://www.optimumcomms.com/wp-content/uploads/2023/02/Neuraxpharm_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-12 09:46:572024-12-12 09:46:57Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies
https://www.optimumcomms.com/wp-content/uploads/2024/12/General-Inception_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-12 08:36:432024-12-12 09:27:50General Inception acquires Enable Medicine and announces strategic partnership to accelerate drug discovery with AI-led generative biological search
https://www.optimumcomms.com/wp-content/uploads/2023/10/splicebio-1.png
1000
1000
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-12 08:33:272024-12-12 08:33:27SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt Disease
https://www.optimumcomms.com/wp-content/uploads/2023/02/Neuraxpharm_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-11 11:54:582024-12-11 11:54:58Leriglitazone has met the primary endpoint in NEXUS, the pivotal trial for pediatric patients with cerebral Adrenoleukodystrophy
https://www.optimumcomms.com/wp-content/uploads/2024/06/iOnctura_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-11 10:37:352024-12-11 10:37:35iOnctura reaches new clinical milestones in uveal melanoma
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ariceum_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2024-12-11 08:39:282024-12-11 08:39:28Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
